Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO Living Guideline (Part 1)

Therapy for Stage IV Non-Small Cell Lung Canc...

Up next

Systemic Therapy in Patients With mCRPC: ASCO Living Guideline 2026.1

Dr. Mary-Ellen Taplin joins the podcast to discuss the latest changes to the living guideline on metastatic castration-resistant prostate cancer (mCRPC). She reviews new treatment options for patients treated with ADT alone, ADT and an ARPI, ADT and docetaxel, and ADT, an ARPI, a ...  Show more

Treatment of Multiple Myeloma: ASCO-OH (CCO) Living Guideline

Dr. Lisa Hicks and Dr. Joseph Mikhael discuss the updated guideline from ASCO and Ontario Health (Cancer Care Ontario) on the treatment of multiple myeloma. They cover recommendations for therapeutic options across smoldering multiple myeloma, transplant eligible multiple myeloma ...  Show more

Recommended Episodes

#328 Updates in Hospital Medicine, Primary Care, Breast Health, Sexual Health, Addiction Medicine, Meded and more! Highlights from #SGIM22
The Curbsiders Internal Medicine Podcast

Fill up with delicious practice-changing knowledge food from #SGIM22 as The Curbsiders team discusses breast cancer survivorship, sexual dysfunction, How climate change will affect health, Are PT consults necessary in the hospital?, Do we need antibiotics for aspiration events?, ...  Show more

322. Guidelines: 2021 ESC Cardiovascular Prevention – Question #31 with Dr. Eugene Yang
Cardionerds: A Cardiology Podcast

The following question refers to Figures 6-8 from Sections 3.2 of the 2021 ESC CV Prevention Guidelines. The question is asked by student Dr. Hirsh Elhence, answered first by Ohio State University Cardiology Fellow Dr. Alli Bigeh, and then by expert faculty Dr. Eugene Yang. Dr. Y ...  Show more

358. Guidelines: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure – Question #31 with Dr. Javed Butler
Cardionerds: A Cardiology Podcast

The following question refers to Section 9.5 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by Keck School of Medicine USC medical student & former CardioNerds Intern Hirsh Elhence, answered first by Vanderbilt Cardiology Fellow and ...  Show more